The Testosterone Myth? Large Analysis Finds No Link Between the “Macho” Hormone and Risk-Taking

Why It Matters

The findings overturn a long‑standing biological explanation for gender differences in risk behavior, reshaping research in behavioral economics, psychology, and corporate decision‑making.

Key Takeaways

• 52 studies, 17,340 participants show zero overall effect
• Lottery tasks reveal modest positive testosterone‑risk link
• Direct hormone measurements show no association
• No sex differences in testosterone‑risk relationship

Pulse Analysis

The belief that testosterone fuels a "macho" propensity for risk has permeated both academic discourse and popular culture. Evolutionary psychologists and economists have long cited higher average testosterone in men as a biological basis for the observed gender gap in financial and physical risk‑taking. This narrative also underpins corporate leadership stereotypes, where bold decision‑making is often equated with masculine hormone levels. Yet the new meta‑analysis, published in Neuroscience and Biobehavioral Reviews, aggregates data from 52 peer‑reviewed studies, providing the most comprehensive statistical test of the hypothesis to date.

By systematically coding each study’s measurement approach—ranging from saliva assays and administered doses to indirect digit ratio proxies—the researchers uncovered striking methodological heterogeneity. Overall, the pooled effect size was essentially zero, indicating that testosterone alone does not predict whether an individual will gamble, invest, or engage in daring activities. Only a subset of experiments employing lottery‑based economic tasks produced a modest positive correlation, suggesting that the hormone’s influence may be confined to specific decision‑making contexts that mirror financial gambles. Direct hormone measurements and self‑report questionnaires consistently showed no relationship, reinforcing the view that earlier positive findings were likely task‑specific artifacts rather than evidence of a universal effect.

The implications extend beyond academic debate. For businesses, the study cautions against using hormonal profiles as proxies for leadership potential or risk appetite, steering talent assessment toward behavioral and situational metrics. In public policy, it supports initiatives that address gender disparities through cultural and educational interventions rather than biological determinism. Future research may pivot toward the dual‑hormone model, exploring how cortisol interacts with testosterone, or toward neuro‑cognitive pathways that mediate risk perception. Until then, the evidence positions testosterone as a narrow, context‑dependent factor rather than a master regulator of human risk behavior.